Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: A pilot study

Journal of the Neurological Sciences

Volumn 313, Issue 1-2, 2012, Pages 22-26

  Nakamura, Tomomi ^a,b   Tsuruta, Shinji ^b   Uchiyama, Shinichiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Itabashi Chuo Medical Center   (Japan)

Author keywords

Acute ischemic stroke; Aspirin; Cilostazol; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL;

AGED; ARTICLE; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DETERIORATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL HEMORRHAGE; HEART PALPITATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECURRENT DISEASE; TREATMENT OUTCOME;

AGED; ASPIRIN; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; PILOT PROJECTS; STROKE; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855578215     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.038     Document Type: Article

References (36)

1. H. Umekawa, T. Tanaka, Y. Kimura, and H. Hidaka Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography Biochem Pharmacol 33 1984 3339 3344 (Pubitemid 15203616)
2. Y. Kimura, T. Tani, T. Kanbe, and K. Watanabe Effect of cilostazol on platelet aggregation and experimental thrombosis Arzneimittelforschung 35 1985 1144 1149 (Pubitemid 15030828)
3. F. Goto, H. Tohgi, S. Hirai, A. Terashi, Y. Fukuuchi, and E. Otomo Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction J Stroke Cerebrovasc Dis 9 2000 147 157 (Pubitemid 30480490)
4. Y. Shinohara, Y. Katayama, S. Uchiyama, T. Yamaguchi, S. Handa, and K. Matsuoka Cilostazol for the prevention of secondary stroke (CSPS2): an aspirin-controlled, double-blind, randomized non-inferiority trial Lancet Neurol 9 2010 959 968
5. Y. Huang, Y. Cheng, J. Wu, Y. Li, E. Xu, and Z. Hong Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study Lancet Neurol 7 2008 494 499
6. A.K. Kamal, I. Naqvi, M.R. Husain, and B.A. Khealani Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin (review) Cochrane Database Syst Rev 2011 CD008076
7. Z.M. Chen, P. Sandercock, H. Pan, C. Counsell, R. Collins, and L. Liu Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the international stroke trial Stroke 31 2000 1240 1249 (Pubitemid 30351240)
8. M.R. Buchanan, L. Schwartz, M. Bourassa, S.J. Brister, and C.M. Peniston Results of the BRAT study: a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery Can J Cardiol 16 2000 1385 1390 (Pubitemid 32094223)
9. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965 (Pubitemid 36315537)
10. A. Mirkhel, E. Peyster, J. Sundeen, L. Greene, A.D. Michelson, and A. Hasan Frequency of aspirin resistance in a community hospital Am J Cardiol 98 2006 577 579 (Pubitemid 44233448)
11. S. Uchiyama, T. Nakamura, M. Yamazaki, and Y. Kimura New modalities and aspects of antiplatelet therapy for stroke prevention Cerebrovasc Dis 21 suppl 1 2006 7 16 (Pubitemid 43254156)
12. A. Roden-Julling Progressing stroke: epidemiology Cerebrovasc Dis 7 suppl 5 1997 2 5
13. D. Toni, M. Fiorelli, M. Gentile, S. Bastianello, M.L. Sacchetti, and C. Argentino Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis Arch Neurol 52 1995 670 675
14. W. Steinke, and S.C. Ley Lacunar stroke is the major cause of progressive motor deficits Stroke 33 2002 1510 1516 (Pubitemid 34619949)
15. Y. Yamamoto, T. Ohara, M. Hamanaka, A. Hosomi, A. Tamura, and I. Akiguchi Predictive factors for progressive motor deficits in penetrating artery infarctions in two different arterial territories J Neurol Sci 288 2010 170 174
16. T. Nakamura, H. Houchi, A. Minami, S. Sakamoto, K. Tsuchiya, and Y. Niwa Endothelium-dependent relaxation by cilostazol, a phosphodiesterase III inhibitor, on rat thoracic aorta Life Sci 69 2001 1709 1715 (Pubitemid 32785280)
17. K. Nakamura, F. Ikomi, and T. Ohhashi Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles J Vasc Res 43 2006 86 94 (Pubitemid 41832710)
18. H. Iida, M. Iida, M. Takenaka, N. Fukuoka, and S. Dohi Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking rats J Thromb Thrombolysis 29 2010 483 488
19. A. Hashimoto, G. Miyakoda, Y. Hirose, and T. Mori Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism Atherosclerosis 189 2006 350 357 (Pubitemid 44634499)
20. M. Otsuki, H. Saito, X. Xu, S. Sumitani, H. Kouhara, and M. Kurabayashi Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-κB binding to its recognition sequence Atherosclerosis 158 2001 121 128 (Pubitemid 32735475)
21. S.K. Woo, W.K. Kang, and K.I. Kwon Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans Clin Pharmacol Ther 71 2002 246 252 (Pubitemid 34311453)
22. H.P. Adams, B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41 (Pubitemid 23014379)
23. H.P. Adams, G.J. del Zoppo, M.J. Alberts, D.L. Bhatt, L. Brass, and A. Furlan Guidelines for the early management of adults with ischemic stroke. A guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups Stroke 38 2007 1655 1711 (Pubitemid 46691097)
24. S. Takahashi, K. Oida, R. Fujiwara, H. Maeda, S. Hayashi, and H. Takai Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture J Cardiovasc Pharmacol 20 1992 900 906 (Pubitemid 23001455)
25. Y. Nonaka, K. Tsuruma, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage Neurosci Lett 452 2009 156 161
26. F. Honda, H. Imai, M. Ishikawa, C. Kubota, T. Shimizu, and M. Fukunaga Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia Stroke 37 2006 223 228 (Pubitemid 43732075)
27. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
28. P.A. Howard Aspirin resistance Ann Pharmacother 36 2002 1620 1624
29. L. Marquardt, A. Ruf, U. Mansmann, R. Winter, M. Schuler, and F. Buggle Course of platelet activation markers after ischemic stroke Stroke 33 2002 2570 2574 (Pubitemid 35266425)
30. H.C. Diener, J. Bogousslavsky, L.M. Brass, C. Cimminiello, L. Csiba, and M. Kaste Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high risk patients (MATCH): randomized, double-blind, placebo-controlled trial Lancet 364 2004 331 337
31. J. Kennedy, M.D. Hill, K.J. Ryckborst, M. Eliasziw, A.M. Demchuk, and A.M. Buchan Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial Lancet Neurol 6 2007 961 969 (Pubitemid 47562312)
32. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
33. R.L. Sacco, H.C. Diener, S. Yusuf, D. Cotton, S. Ounpuu, and W.A. Lawton PRoFESS study group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 2008 1238 1251
34. D.M. Meyer, K.C. Albright, T.A. Allison, and J.C. Grotta LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack J Stroke Cerebrovasc Dis 17 2008 26 29
35. D.B. Wilhite, A.J. Comerota, F.A. Schmieder, R.C. Throm, J.P. Gaughan, and A.K. Rao Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time J Vasc Surg 38 2003 710 713 (Pubitemid 37254796)
36. S. Uchiyama, B.M. Demaerschalk, S. Goto, Y. Shinohara, F. Gotoh, and W.M. Stone Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials J Stroke Cerebrovasc Dis 18 2009 482 490